IRMD Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
IRadimed Corp (IRMD) is a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The company demonstrates strong financial growth, positive analyst sentiment, and bullish technical indicators. Although there are no recent news catalysts or significant trading trends, the stock's fundamentals and analyst confidence make it a solid choice for a long-term investment.
The MACD is positive and expanding (0.0742), indicating bullish momentum. The RSI is neutral at 58.871, and moving averages are bullish (SMA_5 > SMA_20 > SMA_200). The stock is trading above its pivot level (101.229), with resistance at 104.067 and support at 98.391, suggesting a favorable technical setup.
Strong financial performance in Q4 2025, with revenue up 17.03% YoY, net income up 25.17% YoY, and EPS up 25.00% YoY.
Analysts have raised price targets to $120, citing strong execution and profitability.
Bullish technical indicators support upward price momentum.
Gross margin dropped slightly (-1.41% YoY).
No recent news or significant trading trends to act as immediate catalysts.
In Q4 2025, revenue increased to $22.69M (up 17.03% YoY), net income rose to $6.44M (up 25.17% YoY), and EPS improved to 0.5 (up 25.00% YoY). Gross margin slightly declined to 75.06% (-1.41% YoY), but overall financials remain strong.
Analysts from Lake Street and Roth Capital raised their price targets to $120, maintaining Buy ratings. They cited strong Q4 results, higher forward estimates, and confidence in the company's execution and profitability.
